Ken Griffin Io Biotech, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Io Biotech, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 45,555 shares of IOBT stock, worth $95,665. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,555
Previous 270,504
83.16%
Holding current value
$95,665
Previous $248,000
80.24%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IOBT
# of Institutions
21Shares Held
19MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA6.17MShares$13 Million1.83% of portfolio
-
Novo Holdings Hellerup, G73.35MShares$7.04 Million0.33% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.34MShares$4.92 Million0.2% of portfolio
-
Marshall Wace, LLP London, X02.11MShares$4.42 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.65MShares$3.47 Million0.0% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $60.5M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...